Revolutionary treatment for inoperable lung cancer is assessed in first US trial
This article was originally published in Clinica
Executive Summary
In the first US trial of its kind, a team from Indiana is to assess stereotactic body radiotherapy as a treatment for patients with primary lung cancer who are poor candidates for major lung surgery.